Chemoinformaics analysis of 10-Nonadecenoic acid Methyl Ester
| Molecular Weight | 310.522 | nRot | 16 |
| Heavy Atom Molecular Weight | 272.218 | nRig | 2 |
| Exact Molecular Weight | 310.287 | nRing | 0 |
| Solubility: LogS | -6.831 | nHRing | 0 |
| Solubility: LogP | 7.944 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 60 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 38 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 60.3421 |
| nHD | 0 | BPOL | 40.7259 |
| QED | 0.183 |
| Synth | 2.082 |
| Natural Product Likeliness | 0.694 |
| NR-PPAR-gamma | 0.235 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.006 |
| HIA | 0.004 |
| CACO-2 | -4.746 |
| MDCK | 0.0000154 |
| BBB | 0.143 |
| PPB | 0.973791 |
| VDSS | 3.289 |
| FU | 0.0174749 |
| CYP1A2-inh | 0.568 |
| CYP1A2-sub | 0.189 |
| CYP2c19-inh | 0.425 |
| CYP2c19-sub | 0.065 |
| CYP2c9-inh | 0.257 |
| CYP2c9-sub | 0.953 |
| CYP2d6-inh | 0.215 |
| CYP2d6-sub | 0.082 |
| CYP3a4-inh | 0.497 |
| CYP3a4-sub | 0.05 |
| CL | 5.501 |
| T12 | 0.218 |
| hERG | 0.268 |
| Ames | 0.005 |
| ROA | 0.011 |
| SkinSen | 0.971 |
| Carcinogencity | 0.099 |
| EI | 0.959 |
| Respiratory | 0.709 |
| NR-Aromatase | 0.096 |
| Antiviral | No |
| Prediction | 0.564918 |